IRMD
Iradimed Co
85.80$
+0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 22.2% | 23.1% | 23.9% | 21.9% | 22.6% | 23.9% | 23.9% | 21.8% | 22.2% | 24.9% | 23.5% | 25.9% | 24.1% | |
| 77.8% | 76.9% | 76.1% | 78.1% | 77.4% | 76.1% | 76.1% | 78.2% | 77.8% | 75.1% | 76.5% | 74.1% | 75.9% | |
| 2.7% | 3.7% | 4.7% | 4.5% | 3.5% | 2.9% | 3.2% | 4.3% | 3.2% | 3.5% | 4.3% | 3.2% | 3.6% | |
| 21.9% | 24.5% | 22.7% | 22.9% | 21.7% | 20.0% | 23.6% | 21.0% | 20.5% | 20.0% | 20.8% | 18.9% | 20.1% | |
| 42.0% | 47.3% | 49.1% | 46.8% | 45.9% | 46.2% | 48.2% | 44.9% | 45.6% | 43.8% | 43.6% | 42.8% | 43.9% | |
| 35.8% | 29.6% | 27.0% | 31.4% | 31.6% | 29.9% | 27.8% | 33.3% | 32.2% | 31.3% | 32.9% | 31.2% | 31.9% | |
| – | 2.0% | – | – | – | – | – | – | – | – | – | – | – | |
| 38.8% | 32.6% | 29.8% | 35.0% | 35.0% | 32.7% | 30.5% | 35.9% | 34.4% | 34.3% | 35.3% | 33.7% | 34.5% | |
| 8.1% | 6.5% | 6.3% | 7.6% | 7.5% | 6.2% | 6.4% | 7.6% | 8.1% | 5.9% | 8.9% | 8.2% | 7.7% | |
| 30.7% | 26.0% | 23.5% | 27.3% | 27.6% | 26.5% | 24.0% | 28.3% | 26.3% | 28.4% | 26.5% | 25.5% | 26.7% | |
| 40.0% | 33.7% | 31.1% | 36.1% | 36.1% | 33.7% | 31.5% | 38.8% | 36.2% | 37.0% | 37.4% | 33.2% | 36.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.